Stay updated on CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial
Sign up to get notified when there's something new on the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page.

Latest updates to the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference5%

- Check26 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.1%

- Check33 days agoChange DetectedBrand name changed from Coherus Biosciences, Inc. to Coherus Oncology, Inc.SummaryDifference0.5%

- Check40 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, indicating a minor patch. The Back to Top link was removed; no other substantive changes to core content (pricing, stock, or time-based information).SummaryDifference0.3%

- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.3%

- Check55 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and previous revision information have been removed.SummaryDifference2%

Stay in the know with updates to CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHS-1701 vs Neulasta PK/PD Biosimilarity Clinical Trial page.